Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial
Fiona M Walter(Queen Mary University of London), Jon Emery(The University of Melbourne), Per Hall(Karolinska Institutet), P. Norris(Cambridge University Hospitals NHS Foundation Trust), Helen Morris(University of Cambridge), Nigel Burrows(Addenbrooke's Hospital), Lucy Bradshaw(University of Nottingham), A Toby Prevost(King's College London), Ed Wilson(University of East Anglia), J. Walls(Norfolk and Norwich University Hospital), Elka Humphrys(Cancer Research UK), Ann Louise Kinmonth(University of Southampton), Margaret Johnson
Cited by 68
Related Papers
The 2017 international classification of the Ehlers–Danlos syndromes
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|1.9k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716
MicroRNA Related Polymorphisms and Breast Cancer Risk
|PLoS ONE|2014|638